Fiduciary Trust’s Tandem Diabetes Care TNDM Stock Holding History

Fiduciary Trust’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,447	Closed	-$208K	–	902
2025 Q4	$208K	Buy	+9,447	New	+$170K	﹤0.01%	833

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fiduciary Trust's TNDM Position: Q1 2026 in Review

Fiduciary Trust sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,447 shares — an estimated $208K sold.

Fiduciary Trust first reported a position in TNDM in Q4 2025 and held it in 1 quarter. The position peaked at $208K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

Fiduciary Trust reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
Fiduciary Trust sold 9,447 Tandem Diabetes Care shares in Q1 2026, an estimated $208K.
Fiduciary Trust first reported a position in Tandem Diabetes Care in Q4 2025 and held it in 1 quarter.
Fiduciary Trust's Tandem Diabetes Care position peaked at $208K in Q4 2025.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.